Noile-Immune Biotech Inc.

4893・Growth Market・Pharmaceuticals

Official website

Noile-Immune Biotech Inc.

4893・Growth Market・Pharmaceuticals

Official website

Noile-Immune Biotech Inc.4893

Reference Indicators

Market Cap

61¥100M

P/E (Forecast)

—

P/B

1.6x

Dividend Yield (Forecast)

0.00%

ROE

-20.2%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2023Dec 2023	2024Dec 2024	2025Dec 2025
Net Sales	316	7	5
Operating Income	-775	-1,069	-797
Non-operating Income	0	107	6
Non-operating Expenses	352	0	0
Ordinary Income	-1,127	-962	-791
Pre-tax Income	-1,127	-962	-791
Income Taxes	2	2	2
Net Income	-1,130	-964	-793
Operating Margin	-244.7%	-14092.3%	-15945.1%
ROA	-19.6%	-20.1%	-19.8%
ROE	-19.9%	-20.4%	-20.2%